A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
12/1999
12/28/1999	US6008247 2,4-bis[(4-amidino)phenyl]furans as anti-Pneumocystis carinii agents
12/28/1999	US6008231 Antiallergens, antihistamines, immunosuppressants, immunomodulators
12/28/1999	US6008215 Benzonaphthyridines as bronchial therapeutics
12/28/1999	US6008199 Continuously infusing an activated protein c for about 24 to 144 hours
12/28/1999	US6008196 Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
12/28/1999	US6008017 Human cardiac/brain tolloid-like protein
12/28/1999	US6007805 Use of interferon subtype alpha-8 (IFN-α8) to treat viral infections of the liver
12/23/1999	WO1999066047A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999	WO1999066037A2 Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
12/23/1999	WO1999065909A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
12/23/1999	WO1999065908A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
12/23/1999	WO1999065880A1 Aryl alkanoylpyridazines
12/23/1999	WO1999065571A2 Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders
12/23/1999	WO1999065495A1 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB
12/23/1999	WO1999065464A1 Pharmaceutical formulations for aerosols with two or more active substances
12/23/1999	WO1999065449A2 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB
12/23/1999	WO1999065430A1 Adhesively applied external nasal strips and dilators containing medications and fragrances
12/23/1999	WO1999033859A3 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
12/23/1999	DE19827679A1 New pyrazolo(3,4-d)pyrimidine derivative adenosine A3 receptor antagonists, used for treating epilepsy, asthma or allergy
12/23/1999	DE19826841A1 Arylalkanoylpyridazine Arylalkanoylpyridazine
12/23/1999	CA2335294A1 Inhibitors of transcription factor nf-.kappa.b
12/23/1999	CA2335293A1 Inhibitors of transcription factor nf-.kappa.b
12/23/1999	CA2333666A1 Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders
12/23/1999	CA2332173A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/22/1999	EP0964865A2 Pharmaceutically active tricyclic amines
12/22/1999	EP0726893B1 Novel 4-piperidinyl substituted lactames as neurokinin 2 receptor antagonists for the treatment of asthma
12/22/1999	EP0635018B1 4-(1H-2-METHYLIMIDAZO[4,5-c]PYRIDINYLMETHYL)PHENYLSULPHONAMIDE DERIVATIVES AS ANTAGONISTS OF PAF
12/22/1999	CN1239431A Immunogenic TLP compsn.
12/21/1999	US6004974 Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-α]pyridines
12/21/1999	US6004560 Obtaining a liquid by boiling bupleurum scorzonerifolium willd, radix lastidis indigotica and folium lastidis for a long time in water, and then mixing the liquid thus obtained with vitamin c
12/21/1999	US6004556 Staphylococcus aureus RSBU-1
12/21/1999	CA2197075C Method of gene therapy using dna vectors without selection marker gene
12/21/1999	CA2044280C Vitamin d analogues
12/17/1999	CA2235420A1 Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
12/16/1999	WO1999064423A1 Furopyridine derivatives and their therapeutical use
12/16/1999	WO1999064414A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
12/16/1999	WO1999064400A1 INHIBITORS OF p38
12/16/1999	WO1999064398A1 Quarternary ammonium compounds as anti-tussive agents
12/16/1999	WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999	WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064052A1 Novel leukotriene receptor antagonists and their uses
12/16/1999	WO1999064043A1 Muscarinic receptor antagonists
12/16/1999	WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999	WO1999064041A1 Multibinding agents that modulate nmda receptors
12/16/1999	WO1999064039A1 Bradykinin antagonists
12/16/1999	WO1999064038A1 Novel analgesic agents
12/16/1999	WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064029A1 Plant extract
12/16/1999	WO1999064021A1 hCEPR RECEPTOR
12/16/1999	WO1999064014A1 Use of a composition comprising formoterol and budesonide for the prevention or treatment of an acute condition of asthma
12/16/1999	WO1999064011A1 Drugs
12/16/1999	WO1999064004A1 QUINAZOLINONE INHIBITORS OF cGMP PHOSPHODIESTERASE
12/16/1999	WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999	WO1999063999A1 H1-histamine receptor antagonists
12/16/1999	WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999	WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999	WO1999063985A1 Compositions and methods for treatment of cough
12/16/1999	WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
12/16/1999	WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors
12/16/1999	WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors
12/16/1999	WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999	WO1999063931A2 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor
12/16/1999	WO1999063930A2 Novel angiotensin receptor modulators and their uses
12/16/1999	WO1999041368A3 Optimization of immunomodulatory properties of genetic vaccines
12/16/1999	CA2334979A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
12/16/1999	CA2334970A1 Quinazolinone inhibitors of cgmp phosphodiesterase
12/16/1999	CA2334812A1 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor
12/16/1999	CA2334481A1 Compositions and methods for treatment of cough
12/16/1999	CA2334454A1 Quarternary ammonium compounds as anti-tussive agents
12/16/1999	CA2333629A1 Furopyridine derivatives and their therapeutical use
12/16/1999	CA2321273A1 Novel analgesic agents
12/16/1999	CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999	CA2321152A1 Novel therapeutic agents that modulate endothelin receptors
12/16/1999	CA2321120A1 .beta.3-adrenergic receptor agonists
12/16/1999	CA2320926A1 Novel leukotriene receptor antagonists and their uses
12/16/1999	CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999	CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999	CA2319730A1 Bradykinin antagonists
12/16/1999	CA2319651A1 H1-histamine receptor antagonists
12/16/1999	CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999	CA2319497A1 Novel therapeutic agents that modulate estrogen receptors
12/16/1999	CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999	CA2319175A1 Multibinding agents that modulate nmda receptors
12/16/1999	CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999	CA2319068A1 Novel angiotensin receptor modulators and their uses
12/16/1999	CA2318894A1 .beta.2-adrenergic receptor agonists
12/16/1999	CA2318286A1 Multibinding agents that modulate ppar.gamma. and rxr receptors
12/16/1999	CA2318055A1 .beta.2-adrenergic receptor agonists
12/16/1999	CA2315883A1 Muscarinic receptor antagonists
12/15/1999	EP0963431A1 NOVEL FabH
12/15/1999	EP0765305B1 Anti-inflammatory compounds
12/15/1999	EP0725782B1 A 1 adenosine receptor agonists and antiagonists
12/15/1999	EP0664703B1 Methods of combating (pneumocystis carinii) pneumonia and compounds useful therefor
12/15/1999	EP0658110B1 Use of norastemizole for the treatment of allergic rhinitis
12/15/1999	CN1238212A Liquid medicine for treating disseases of eye, ear, nose and throat
12/14/1999	US6001972 Splicing variant of the epstein-barr virus-induced G-protein coupled receptor
12/14/1999	US6001830 Heterocyclic compounds
12/14/1999	US6001819 Bacterial inhibition with an oligosaccharide compound

1 ... 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 ... 878